Miller-Dieker Syndrome (MDS)

Indications for Miller-Dieker Syndrome (MDS)
Individuals affected with Miller-Dieker syndrome are characterized by lissencephaly, mental retardation and a distinct facial appearance

Collection Procedure

  • Amniotic fluid 15-20 ml. Discard the first 2 ml of fluid to reduce the risk of maternal cell contamination. Aseptically transfer the specimen into sterile plastic conical tubes labeled with patient’s name and date of birth.
  • CVS 10-20 mg. Aseptically transfer the specimen into sterile plastic conical tubes containing sterile transport medium. Label tube with patient’s name and date of birth.

A completed test requisition form must be included with every sample. A transport kit is available upon request.

Specimen Requirements
FISH analysis is performed following cytogenetic analysis

Transport Temperature
Room temperature (DO NOT refrigerate, freeze or centrifuge)

Methodology
Laboratory Testing for Miller-Dieker syndrome is performed on metaphase chromosomes utilizing Fluorescence in situ hybridization targeting chromosome 17.

Causes for Rejection
Frozen specimen, inappropriate container

Turnaround Time
24-48 hrs after completion of cytogenetic analysis